StimulatorNeuroPace has received the pre-market nod by FDA for the NeuroPace RNS System, employed in the treatment of medically refractory partial epilepsy.
Electrical activity in the brain is monitored by the battery powered device which is implanted in the cranium. If any abnormal activity is detected, electrical impulses are sent to the seizure focus in the brain via leads, and this assists in preventing the onset of a seizure.
Device That can Help Predict Seizures in Epilepsy Patients Takes a Step Closer to Reality
A new study reports on the development of a new software by American researchers that can help predict when an epilepsy patient may suffer from a seizure.
Advertisement
The RNS System also comprises of a programmer for physicians where they can program the detection and stimulation parameters for the implanted device non-invasively. They can also take a look at the patients' electrocorticogram (ECoG) in real time and upload previously recorded ECoGs stored on the RNS implant.
Results have pointed to benefits to the tune of a 37.9% reduction in seizure frequency for subjects with active implants. More than 50% of people experienced a reduction in seizures of 50% or more.
![Brain Connectivity Can Predict Epilepsy Surgery Outcomes: Research]( "Brain Connectivity Can Predict Epilepsy Surgery Outcomes: Research")
A discovery from the researchers of Case Western Reserve and Cleveland Clinic could provide epilepsy patients invaluable advance guidance about their chances to improve symptoms through surgery.
"The RNS System is indicated for use as an adjunctive therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures who have undergone diagnostic testing that localized no more than two epileptogenic foci, are refractory to two or more antiepileptic medications, and currently have frequent and disabling seizures."
Source: Medindia
Brain Connectivity Can Predict Epilepsy Surgery Outcomes: Research
A discovery from the researchers of Case Western Reserve and Cleveland Clinic could provide epilepsy patients invaluable advance guidance about their chances to improve symptoms through surgery.
Advertisement
"The RNS System is indicated for use as an adjunctive therapy in reducing the frequency of seizures in individuals 18 years of age or older with partial onset seizures who have undergone diagnostic testing that localized no more than two epileptogenic foci, are refractory to two or more antiepileptic medications, and currently have frequent and disabling seizures."
Source: Medindia
Exercise may Cut Epilepsy Risk
Men who engage in physical activity as young adults may reduce their risk of developing epilepsy later in life, reveals study.
Advertisement
Research Indicates Drug Shows Promise in Treating SeizuresA potential new treatment for the seizures that often plague children with genetic metabolic disorders is suggested in a new study. | Advertisement
|
Advertisement
Latest Medical Gadgets
Apart from monitoring basic health, the new apple watch series 9 features a new double tap gesture to control apps without touching the watch.
Our artificial olfactory system combines sensing and processing efficiently, mirroring the biological olfactory system's function for energy and space savings.
A portable, lightweight, and affordable exoskeleton designed for stroke patients promises expanded accessibility, particularly in areas with limited resources.
A textile-based wearable device that 'taps' a user's wrist with pressurized air, silently guides the person finding their way to their destination.
A device controlled through a mobile app, utilizing heat signatures and bacterial fluorescence, helps detect and address infections in wounds.
